drugset / Trial / NCT05691257
Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to conduct a a cohort study to evaluate the efficacy and safety of the efficacy and safety of roxadustat for the treatment of anemia, quality of life and cardiac function in patients with heart failure and chronic kidney disease.
Timeline
- Start
- 2023-02-01
- Primary completion
- 2023-08-01
- Completion
- 2023-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Roxadustat | Small molecule | 70 mg | — |
| Subject | Roxadustat | Small molecule | 100 mg | — |
| Background | Ferrous Sulfate | Diagnostic / imaging agent | — | — |
| Background | Iron sucrose | Unknown | — | — |
| Background | Polysaccharide iron complex | Unknown | — | — |
| Background | Recombinant human eythropoietin | Unknown | — | — |